5. Alimera Sciences (ALIM - Get Report) is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, focusing on diseases affecting the back of the eye, or retina. The company will announce its first quarter results on May 5.
9 Health Care Stocks With 100% Buy Ratings
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.